Molecular determinants of irinotecan efficacy.
Vallböhmer D, Iqbal S, Yang DY, Rhodes KE, Zhang W, Gordon M, Fazzone W, Schultheis AM, Sherrod AE, Danenberg KD, Lenz HJ.
Vallböhmer D, et al.
Int J Cancer. 2006 Nov 15;119(10):2435-42. doi: 10.1002/ijc.22129.
Int J Cancer. 2006.
PMID: 16894565